Alcidion (ASX:ALC) share price storms higher on update

The Alcidion share price is storming higher today as the company released a positive quarterly report. We take a closer look.

| More on:
Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today, the Alcidion Group Ltd (ASX: ALC) share price is storming higher as the company released a positive quarterly report to the market. Shares in the e-health provider are rising strongly despite the sharp sell off in the All Ordinaries Index (ASX: XAO). At the time of writing, the Alcidion share price is trading 4.17% higher at 12.5 cents.

Strong start to the year

Alcidion has posted very strong numbers despite the ongoing impacts of the global pandemic. The healthcare small cap announced $4.8 million in new contracted revenue. This number is up 30% on the previous quarter's results and up a huge 92% from the prior corresponding period (pcp). Despite this sizeable increase in revenue, the Alcidion share price has slumped 40% over the past year.

As a result of the company's surging revenue during the quarter, total contracted revenue to be realised in FY2021 has also increased. Alcidion reported this number stands at $14.7 million. Furthermore, the company reported strong cash receipts from customers of $6.4 million, a 34% increase on a year ago.

Despite the rise in income, Alcidion still reported net cash outflows of $1.2 million. However, it should be noted that this number reflects ongoing investment in growing the business and was in line with the company's expectations.

Alcidion had cash reserves of $14.7 million at the end of the first quarter. 

Comments

Alcidion Managing Director, Kate Quirk, was pleased with the results, stating:

I am pleased with the strong start we have made to the new financial year. It has been an important sales quarter in Australia, where we signed initial contracts with significant potential for future expansion.

We continue to scale up our sales, product implementation and marketing capabilities to accelerate growth in all markets, as healthcare undergoes unprecedented digital transformation. Investment in these areas will remain our focus throughout the financial year to support further growth and firmly establish Alcidion as a leading provider of digital healthcare solutions in this rapidly growing market.

About the Alcidion share price

Alcidion is a Melbourne-based company that is focused on developing a range of software products for use in the healthcare sector. Some of the company's most prominent brands are Miya and Patientrack. These platforms enable medical professionals to better manage their time and patients.

As at October 2020, the company's platforms are utilised by more than 65,000 users across over 300 hospitals in Australia, New Zealand and the United Kingdom.

Despite strong revenue growth over the last couple of years, the Alcidion share price has been on a downward trend since reaching all time highs of 30 cents in September last year. Shareholders will be hoping the company's ongoing revenue growth will help drive a turnaround in the Alcidion share price.

Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Happy woman working on a laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a pleasant end to the trading week for investors this Friday.

Read more »

Close-up of a business man's hand stacking gold coins into piles on a desktop.
Opinions

If I had a big cash pile like Warren Buffett, here's how I'd spend it in 2025

I'd put Buffett's billions to work straight away.

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Up 30% in a month, this ASX 200 tech share is 'a compelling opportunity': expert

Analysts from listed investment company WAM Capital say this ASX 200 tech stock is worth watching.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
52-Week Highs

5 ASX 200 shares hitting multi-year highs after strongly rebounding from tariff turmoil

These stocks have hit new price milestones amid a day in the green for the ASX 200.

Read more »

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
Share Market News

3 key takeaways from the 2025 Macquarie Conference

More than one hundred companies presented at the Macquarie Conference this year. Here’s what we learned.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Share Gainers

Why Chrysos, GQG Partners, Macquarie, and Webjet shares are storming higher today

These shares are ending the week on a positive note. But why?

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Share Gainers

The top 3 ASX 200 trades since the Liberation Day dip

These companies are up at least 35% in just over a month.

Read more »